- Benchmark ASINB0D9WDQ5SC
- MarketplaceDE
- Category ID20633021031
- Analyzed Products
- Keywordunder eye mask, eye patches, anti aging eye mask
- Price Range-
- Minimum Net Profit Margin10.00%
- MOQ100
- Est. Purchasing CostNo price data
- Data Date2026-07-23
- Your Budget (for new listing) (CNY)¥500,000.00
Report summary from Keble AI Agent: Listing
结论很明确：这个市场不值得进入，已经是明显的价格战市场，对大品牌和小品牌都不友好。 当前可识别盈利产品占比为0%，新品牌可识别盈利率也是0%，且新上架产品利润区间直接落在-395.58%到-231.31%，说明不是“利润偏低”，而是结构性亏损。
Recommended Products Features Direction
These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.
New Brands
VS
Old Brands
Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.
Old Brands
#Budget Requirement
Listing结论很明确：不建议进入，这个市场已经接近失效型价格战，且对新卖家并不友好。用户预算50万CNY表面上能覆盖单个ASIN的前期投放，但按当前市场表现看，这笔钱不足以构成安全入场筹码，更不适合拿来赌长期品牌建设。
证据很直接：市场里可识别利润产品占比是0%，新上架产品利润率也是0%；已识别的盈利区间直接落在-23.131%到-39.558%之间，说明不是“赚得少”，而是大概率在亏。 目前样本里，YEAUTY这个老品牌有5个可识别产品，5个全是非盈利；其中B0D2P4DSQ6月销300、售价€0.89、月营收€26,700，但利润率仍是-231.31%，说明这个类目不是靠“跑量”就能救回来。再看B0D9WDQ5SC，月销1,000、月营收€87,000，B0DT172251月销700、月营收€59,500，都是同类常见眼膜形态、功能表达高度重叠，差异化弱，结果仍然没有跑出正利润。市场进入难度为高，且利润难度同样是高，核心原因就是价格竞争严重。按照规则，利润率低于10%属于价格战区，而这里连0%都没站住。
对大品牌和小品牌都不是好机会。 大品牌如果硬进，至少要对标YEAUTY这类老品牌的资源、投放和铺货能力，但即便如此也没有看到正向利润样本；小品牌这边没有任何“真正的小卖家成功案例”可跟，反而更像是被大品牌和高投放玩家挤压的市场。当前没有可见的新品牌盈利样本，也没有新品牌成功率数据支撑“新入场能赢”。如果一定要做，建议只把YEAUTY旗下的B0D9WDQ5SC、B0DT172251、B0D2P4DSQ6当作失败或高压竞品参考，而不是模仿对象；对小卖家来说，这个类目不该进。
Early sourcing + logistics + marketing budget (EUR)N/AExplains the budgetWith all these investments, who has profitable new releases
Alternatives- 咖啡因眼霜/滚珠精华：通常单价更低、使用更方便，不需要敷贴等待，适合日常淡化浮肿和疲劳感。
- 含透明质酸的基础保湿眼部凝胶/啫喱：偏补水与即时舒缓，价格通常低于功能型眼贴，适合把‘补水提亮’作为替代目标。
- 冷敷眼罩/可重复使用的凝胶冰敷眼罩：可直接缓解晨起浮肿和倦容，单次使用成本更低，且不依赖耗材补货。
- 普通保湿面膜裁剪后局部敷眼：如果用户本来就会买全脸面膜，可直接替代一部分眼贴需求，边际成本更低、购买更容易。
- 睡眠贴/热敷蒸汽眼罩：更偏向放松和缓解眼疲劳，使用门槛低，且在‘消肿+舒缓’场景下常被用户拿来替代眼贴。
- 维生素K/咖啡因类眼部打底精华笔：便携、上手快，适合通勤场景；对想要‘快、便宜、随手用’的用户是更容易接受的替代方案。
Alternative solutions may pose a risk to your investment in certain markets.
#Brands Investment Analysis
Listing这个市场不值得进入，结论很直接：已是典型的价格战市场，而且对新品牌几乎没有盈利空间。 已识别产品里可判定的盈利率是0%，新上新产品盈利率也是0%；同时 YEAUTY 这个已入场品牌 5 个可判定产品里 0 个盈利，核心款 B0D2P4DSQ6 虽然月销 300、评分 4.4，但利润率是 -231.3%，最近月利润仍是 -617.59 欧元，说明这里不是“卖不动”，而是“卖得越多亏得越多”。
大品牌视角：能做，但必须带着重投入和差异化才可能挤进去；小品牌视角：不建议做，除非你能做到明显创新，否则大概率被成本和广告吞掉。 现有样本里，YEAUTY 的 B0D9WDQ5SC 月销 1000、月收入 8.7 万欧元；B0D2P4DSQ6 月销 300、月收入 2.67 万欧元，但都仍然非盈利，说明竞争已经卷到高销量也未必赚钱。可复制的不是“同样的普通眼膜形态”，而是它们的基础卖点：补水、淡纹、抗疲劳、快见效；但从数据看，这些卖点已经高度同质化，且没有形成利润。对大品牌，可参考的只有 YEAUTY 的高曝光款 B0D9WDQ5SC 和 B0D2P4DSQ6，前者预算相当于至少先跑出 1000 单/月级别，后者早期投入约 309.72 欧元但仍亏损，说明预算并不能解决结构性问题。
小品牌必须避开的点也很明确：不要做公模眼贴、不要做泛人群定位、不要指望靠 300+ 评论自然起量。 B0D2P4DSQ6 有 363 条评论、B0D9WDQ5SC 有 420 条评论，这种评论量已经非常像高压投放型竞争，不适合作为小品牌成功样本；真正的小品牌成功案例在这组数据里没有出现。市场趋势也是偏坏的：新上新产品没有盈利，整体盈利率 0%，这就是典型的高风险、低回报、价格战区。结论：不要进场。 如果硬要做，只适合资金更强的大品牌做私模/强差异化/品牌心智战，小品牌不具备可行性。
Old brand with the most profitable new productsYEAUTY
Recent Monthly Revenue (EUR):-(-)B0DZHXMFHVBrand is an old entry in this marketOld ReleaseInsufficient Sales to Meet MOQOld ReleaseNot enough sales volume to meet 100 MOQ
Recent Monthly Revenue (EUR):-(-)B0DV9Z3S26Brand is an old entry in this marketOld ReleaseInsufficient Sales to Meet MOQOld ReleaseNot enough sales volume to meet 100 MOQRecent Monthly Revenue (EUR):€267,00(300pcs/month)B0D2P4DSQ6 (4.4/5 (363 Reviews))Brand is an old entry in this marketOld ReleaseSufficient Sales to Meet MOQOld ReleaseNet profit margin below 10.00%#Differentiations
Unique productsCommon productsDifferentiation:- 粉紫色包装更醒目，货架点击率高
- |
- 维C+透明质酸配方，提亮卖点更直观
- |
- 定位消肿提亮，适合日常快速护理
B0D9WDQ5SC (4.5/5 (420 Reviews))Brand is an old entry in this marketOld ReleaseSufficient Sales to Meet MOQOld ReleaseNet profit margin below 10.00%Sales & BSR
Differentiation:- 紫色渐变视觉差异最明显
- |
- 视黄醇主题更强，抗老感突出
- |
- 适合想改善细纹的目标人群
B0D2P4DSQ6 (4.4/5 (363 Reviews))Brand is an old entry in this marketOld ReleaseSufficient Sales to Meet MOQOld ReleaseNet profit margin below 10.00%Sales & BSR
#Net Profit Margins: All vs New
Listing结论很明确：这个市场不值得进入，已经是高风险、价格战主导的市场。 新品利润率几乎全线崩塌，当前样本里可识别利润的产品里 0% 处于盈利状态，而且新发布产品的利润区间落在 -395.58% 到 -231.31%，这不是可优化的小问题，而是结构性亏损。
Profitability difficultyHigh Risk Due to Price CompetitionAll products distribution on different profit levels
All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.
x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%other#Top Products by Net Profit Margin
Top 20 Non-Profitable Products
Products with negative profitability ranked by lowest profit value. Only includes products classified as non-profitable regardless of release date.
B0DT172251YEAUTY2025-01-14No€0.85700pcs€595.0-434.38%€-2584.56B0D9WDQ5SCYEAUTY2024-07-22No€0.871000pcs€870.0-239.45%€-2083.21B0D2P4DSQ6YEAUTY2024-04-25No€0.89300pcs€267.0-231.31%€-617.59B0DZHXMFHVYEAUTY2025-03-06No€--pcs€--%€-B0DV9Z3S26YEAUTY2025-01-28No€--pcs€--%€-No profitable product data available for new products#New Product Success Rates
Listing这个市场不适合进入：样本里可识别的盈利产品占比为0%，新品牌可识别盈利率也是0%，而头部产品几乎都在亏钱；这不是可复制的成功，而是明显的价格战和高风险市场。 现有数据里，YEAUTY 这个老品牌把样本利润打成了负值核心：B0D9WDQ5SC 月销1000、收入€870、利润率-239.4%，最近月利润-€2083.21；B0D2P4DSQ6 月销300、收入€267、利润率-231.31%；B0DT172251 月销700、收入€595、利润率-434.38%。这说明市场里“能卖”不等于“能赚”，而是靠低价硬撑，进入后很难把利润拉回来。
No data availableNo data availableNo data available#Success Rate by Entry Time
Listing这个市场不值得进入，结论很明确：已处于极端价格战/过度竞争状态。 现有数据里，市场样本的可判定产品盈利率是0%，新发布产品盈利率也是0%；利润分布几乎全部落在亏损区间，已不是“可优化进入”，而是“进去先亏”的市场。
How many products released each year
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
How many products released each month
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
#Net Profit Margins by Entry Time
Different profit ratios of products released in year
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
Time/Profit% x < -10.0% -10.0% <= x < 0.0% 0.0% <= x < 10.0% 10.0% <= x < 20.0% 20.0% <= x < 30.0% 30.0% <= x < 40.0% x >= 40.0% other 2022 0 0 0 0 0 0 0 0 2023 0 0 0 0 0 0 0 0 2024 0 0 0 0 0 0 0 0 2025 0 0 0 0 0 0 0 0 2026 0 0 0 0 0 0 0 0 ≥ 10% Profitable< 10% UnprofitableUnidentifiableDifferent profit ratios of products released in month
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
Time/Profit% x < -10.0% -10.0% <= x < 0.0% 0.0% <= x < 10.0% 10.0% <= x < 20.0% 20.0% <= x < 30.0% 30.0% <= x < 40.0% x >= 40.0% other 2025/7 0 0 0 0 0 0 0 0 2025/8 0 0 0 0 0 0 0 0 2025/9 0 0 0 0 0 0 0 0 2025/10 0 0 0 0 0 0 0 0 2025/11 0 0 0 0 0 0 0 0 2025/12 0 0 0 0 0 0 0 0 2026/1 0 0 0 0 0 0 0 0 2026/2 0 0 0 0 0 0 0 0 2026/3 0 0 0 0 0 0 0 0 2026/4 0 0 0 0 0 0 0 0 2026/5 0 0 0 0 0 0 0 0 2026/6 0 0 0 0 0 0 0 0 ≥ 10% Profitable< 10% UnprofitableUnidentifiable#Case Study
Success Cases